Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose prednisone maintenance after high-dose dexamethasone for relapsed chronic/persistent adult primary immune thrombocytopenia
ChiCTR2100053604Phase 4Recruiting
- Sponsor
- Guangxi Medical University Second Affiliated Hospital
- Start
- Aug 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of prednisone and dexamethasone in immune thrombocytopenia (ITP) (2 arms), sponsored by Guangxi Medical University Second Affiliated Hospital. Primary endpoint: Time to relapse. Started Aug 2023; status: recruiting.
02
Drugs
prednisonedexamethasone
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on ChiCTR2100053604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053604.